New oral antithrombotics: a need for laboratory monitoring. For

J Thromb Haemost. 2010 Apr;8(4):621-6. doi: 10.1111/j.1538-7836.2010.03764.x. Epub 2010 Jan 21.
No abstract available

MeSH terms

  • Administration, Oral
  • Anticoagulants / administration & dosage*
  • Anticoagulants / adverse effects
  • Blood Coagulation / drug effects*
  • Blood Coagulation Tests*
  • Drug Monitoring / methods*
  • Evidence-Based Medicine
  • Fibrinolytic Agents / administration & dosage*
  • Fibrinolytic Agents / adverse effects
  • Hemorrhage / chemically induced
  • Heparin / administration & dosage
  • Humans
  • Predictive Value of Tests
  • Risk Assessment
  • Risk Factors
  • Vitamin K / antagonists & inhibitors
  • Warfarin / administration & dosage

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Vitamin K
  • Warfarin
  • Heparin